New York, New York 10021

  • Neoplasms


We have developed an 8-week Meaning-Centered Group Psychotherapy designed to help patients with advanced cancer sustain or enhance a sense of meaning, peace and purpose despite the limitations of their cancer illness. This project's overall aim is to explore the feasibility and efficacy of this new and unique psychotherapy intervention for advanced cancer patients in enhancing psychological and spiritual well-being and quality of life by comparing it with a standard supportive group psychotherapy.

Study summary:

As per Brief Summary


Inclusion Criteria: - 21 years of age or older; - English speaking; - Stage III or IV solid-tumor or Non-Hodgkin's Lymphoma; - Receiving ambulatory care at Memorial Sloan-Kettering Cancer Center in New York City; Exclusion Criteria: - Significant psychiatric disturbance sufficient, in the investigator's judgment, to preclude participation in a group-format intervention; - Presence of cognitive impairment disorder, such as delirium or dementia that is sufficient, in the investigator's opinion, to preclude meaningful participation and/or informed consent; - Karnofsky Performance Rating Scale below 50 or physical limitations or illness severity sufficient to preclude participation in outpatient group psychotherapy.



Primary Contact:

Principal Investigator
William Breitbart, MD
Memorial Sloan-Kettering Cancer Center

Backup Contact:


Location Contact:

New York, New York 10021
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source:

Date Processed: March 26, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on The form below is not enabled.